New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS Biotech Investing
Life Science Big News Roundup: BriaCell Presents Positive Efficacy Data with Lead Cancer Drug Candidate; Kalytera Announces Additional Share Issuance for Services under Payments Agreement with Salzman Group Life Science Investing
Viveve Announces Positive 12-Month Data from Stress Urinary Incontinence Feasibility Study Medical Device Investing
Globus Medical Enters International Market with ExcelsiusGPS Robotic Guidance and Navigation System Medical Device Investing
iCAD Announces FDA Clearance of ProFound AI for Digital Breast Tomosynthesis Medical Device Investing
